Chelsea Pinnix
#117,824
Most Influential Person Now
American oncologist
Chelsea Pinnix's AcademicInfluence.com Rankings
Chelsea Pinnixphilosophy Degrees
Philosophy
#12093
World Rank
#16748
Historical Rank
Logic
#8916
World Rank
#11223
Historical Rank
Download Badge
Philosophy
Chelsea Pinnix's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Chelsea Pinnix Influential?
(Suggest an Edit or Addition)According to Wikipedia, Chelsea Camille Pinnix is an American oncologist who is an Associate Professor of Radiation Oncology and Director of the Residency Program at the MD Anderson Cancer Center . Having joined the faculty 2012, her research looks to improve the outcomes of patients who suffer from lymphoma.
Chelsea Pinnix's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience (2014) (332)
- Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. (2005) (325)
- Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. (2006) (272)
- Active Notch1 confers a transformed phenotype to primary human melanocytes. (2009) (110)
- Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. (2015) (103)
- Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. (2013) (92)
- Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma (2014) (90)
- Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma. (2020) (90)
- Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. (2011) (83)
- Radiation Induces Acute Alterations in Neuronal Function (2012) (79)
- Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution. (2015) (74)
- Cardiac atlas development and validation for automatic segmentation of cardiac substructures. (2017) (69)
- Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. (2018) (68)
- Outcomes of malignant tumors of the lacrimal apparatus (2011) (65)
- The many faces of Notch signaling in skin-derived cells. (2007) (63)
- Fertility drugs and the risk of breast cancer: a meta-analysis and review (2010) (63)
- Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2017) (61)
- Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma (2021) (59)
- Palliative Reirradiation for Progressive Diffuse Intrinsic Pontine Glioma (2012) (58)
- Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. (2018) (57)
- Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma. (2017) (54)
- A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma (2019) (54)
- Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. (2013) (53)
- Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. (2012) (52)
- Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. (2012) (49)
- Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma (2017) (49)
- Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. (2012) (47)
- Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. (2020) (44)
- Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma. (2020) (43)
- Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. (2015) (42)
- Pre‐treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma (2018) (42)
- Double epigenetic modulation of high‐dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor‐risk relapsed lymphoma (2016) (41)
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. (2015) (38)
- Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. (2012) (33)
- Myelopathy following intrathecal chemotherapy in adults: a single institution experience (2015) (33)
- Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. (2015) (32)
- Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy (2016) (32)
- CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. (2021) (30)
- Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (29)
- Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. (2016) (27)
- Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy (2019) (27)
- The Management of Lymphoma in the Setting of Pregnancy (2017) (26)
- Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. (2018) (25)
- Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients. (2014) (23)
- Why Racial Justice Matters in Radiation Oncology (2020) (23)
- Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2018) (22)
- Dorsal column myelopathy after intrathecal chemotherapy for leukemia (2017) (21)
- Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. (2019) (21)
- Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. (2016) (21)
- Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. (2018) (20)
- Comprehensive craniospinal radiation for controlling central nervous system leukemia. (2014) (19)
- ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma. (2016) (17)
- A multi‐institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation (2017) (17)
- Stage I-II Nodular Lymphocyte-Predominant Hodgkin Lymphoma: a Multi-institutional Experience of Adult Patients by ILROG. (2020) (16)
- Linguistic Biases in Letters of Recommendation for Radiation Oncology Residency Applicants from 2015 to 2019 (2020) (16)
- Radiation-related heart and vascular disease. (2015) (16)
- Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. (2017) (15)
- Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors (2015) (15)
- Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. (2018) (15)
- Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma. (2017) (14)
- Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. (2019) (13)
- An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement (2019) (13)
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. (2016) (13)
- A phase 1 b clinical trial of the CD 40-activating antibody CP-870 , 893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma (2015) (12)
- Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma* (2017) (12)
- Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy (2021) (12)
- Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma. (2018) (11)
- Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration (2015) (11)
- Clinical and Radiological Correlates of Neurotoxicity after Standard of Care Axicabtagene Ciloleucel in Patients with Relapsed/Refractory Large B-Cell Lymphoma (2019) (11)
- Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function* (2020) (11)
- Early‐stage Hodgkin lymphoma outcomes after combined modality therapy according to the post‐chemotherapy 5‐point score: can residual pet‐positive disease be cured with radiotherapy alone? (2017) (10)
- Decreased heart dose with deep inspiration breath hold for the treatment of gastric lymphoma with IMRT (2020) (10)
- Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure* (2018) (10)
- Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing With Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma (2020) (10)
- High Risk Diffuse Large B Cell Lymphoma: A Comparison of Aggressive Subtypes Treated with Dose Adjusted Chemotherapy-the University of Texas MD Anderson Experience (2016) (10)
- Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma. (2017) (10)
- Double Hit Lymphoma: M.D. Anderson Experience (2013) (9)
- Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel). (2020) (9)
- Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma (2021) (9)
- Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa‐associated Lymphoid Tissue (2019) (9)
- Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. (2019) (9)
- Haemophagocytic lymphohistiocytosis (HLH) in patients with large B-cell lymphoma treated with standard of care (SOC) axicabtagene ciloleucel (Axi-cel). (2020) (9)
- Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma. (2018) (8)
- Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study (2021) (8)
- Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. (2017) (8)
- Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. (2016) (8)
- Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. (2019) (8)
- Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy (2018) (8)
- Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy (2020) (8)
- New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity (2020) (7)
- Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma (2017) (7)
- Radiation Therapy Can be an Effective Bridging Strategy Prior to Axicabtagene Ciloleucel Therapy for Relapsed/Refractory Large B-Cell Lymphoma (2019) (7)
- Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma (2019) (7)
- Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies. (2016) (7)
- Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma. (2019) (7)
- Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents. (2020) (7)
- Breast Implant-associated Anaplastic Large Cell Lymphoma (2020) (6)
- Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions (2017) (6)
- Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma? (2016) (6)
- DIBH-IMRT treatment to the mediastinum for lymphoma patients: Setup uncertainties and margins (2017) (6)
- Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma (2019) (6)
- Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis (2021) (6)
- Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma (2018) (6)
- Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography (2019) (5)
- Potential Implications of the New USMLE Step 1 Pass/Fail Format for Diversity Within Radiation Oncology (2020) (5)
- Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides (2018) (5)
- Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated? (2019) (5)
- Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery†. (2015) (5)
- PET Guided Therapy for Early Stage Hodgkin Lymphoma - Are We Positive About a Negative Interim Scan? (2020) (4)
- A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma. (2020) (4)
- Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium SocietyTM Appropriate Use Criteria. (2021) (4)
- Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma (2022) (4)
- Deep-Inspiration Breath-Hold Intensity Modulated Radiation Therapy to the Mediastinum for Lymphoma Patients: Setup Uncertainties and Margins. (2017) (4)
- Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors (2020) (4)
- Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports (2016) (4)
- Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis (2021) (4)
- The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy (2021) (3)
- Quality of life in cancer care. (2021) (3)
- Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. (2012) (3)
- Daily computed tomography image guidance: dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma. (2020) (3)
- Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes. (2019) (3)
- PET/CT in a patient with adenoma malignum of the uterine cervix. (2011) (3)
- Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy (2018) (3)
- Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria (2020) (3)
- Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes? (2019) (3)
- Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant (2022) (3)
- SU-E-T-404: Simple Field-In-Field Technique for Total Body Irradiation in Large Patients. (2014) (2)
- Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up (2021) (2)
- Primary Gastric Diffuse Large B-Cell Lymphoma Treated with Abbreviated Chemoimmunotherapy and Contemporary Radiation Therapy has Excellent Outcomes with Minimal Toxicity (2018) (2)
- Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017 (2018) (2)
- Potential Impact of Consolidation Radiation Therapy for Advanced Hodgkin Lymphoma: A Secondary Modeling of SWOG S0816 with Receiver Operating Characteristic Analysis (2018) (2)
- Radiation Therapy for Refractory High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements (2020) (2)
- Effectiveness of Radiation Treatment in Adult Patients With Mediastinal T Cell Lymphoblastic Leukemia/Lymphoma (2016) (2)
- Thirty Year Experience with Rosai Dorfman Disease treated with Radiation, Chemotherapy, and/or Surgery. (2018) (2)
- Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM (2015) (2)
- Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease. (2015) (2)
- Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms (2018) (2)
- Oral Scientific SessionsRainbows and Butterflies: Individualized IMRT Planning for Mediastinal Lymphoma (2017) (2)
- Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement (2020) (2)
- Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy (2019) (2)
- More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone. (2016) (1)
- CD4:CD8 Ratio in Mycosis Fungoides: Prognostic and Predictive Value of Circulating T Lymphocyte Subsets for Outcomes After Total Skin Electron Beam Radiation. (2016) (1)
- Image Guided Radiation Therapy Proves its Benefit in Detecting the Daily Unpredictable Shape Change of the Stomach: A Study of Patients Treated for Stomach Lymphoma (2013) (1)
- Association of Vitamin D Deficiency with Inferior Treatment Outcomes in Patients with Newly Diagnosed Classic Hodgkin Lymphoma: MD Anderson Cancer Center Experience (2020) (1)
- Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET-CT-documented First Remission. (2020) (1)
- Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma (2020) (1)
- Erratum to: Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma: Low-dose radiotherapy for adnexal b-cell lymphoma (Head & Neck, (2017), 39, 6, (1095-1100), 10.1002/hed.24717) (2019) (1)
- Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma (2016) (1)
- Management and Prevention of Breast Cancer After Radiation to the Chest for Childhood, Adolescent, and Young Adulthood Malignancy (2016) (1)
- Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma (2015) (1)
- Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717) (2018) (1)
- Intensity Modulated Radiation Therapy (IMRT) Using Butterfly Technique Offers a Dosimetric Advantage to Critical Organs in Young Female Patients With Mediastinal Hodgkin Lymphoma (2013) (1)
- STAGE I‐II NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA IN THE MODERN ERA: A MULTI‐INSTITUTIONAL EXPERIENCE OF ADULT PATIENTS BY ILROG (2019) (1)
- High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) with Consolidative Radiation Therapy (RT) for Relapsed or Refractory (R/R) Primary Mediastinal B-Cell Lymphoma (PMBCL): 20-Year Experience at MD Anderson Cancer Center (MDACC) (2020) (1)
- Treatment outcomes and prognostic factors for primary mediastinal B-cell lymphoma: The MD Anderson experience. (2014) (1)
- Low-Dose (4 Gy) Radiation Therapy as an Effective Treatment Modality for Relapsed Refractory Mantle Cell Lymphoma (2018) (1)
- Radiation therapy of extranodal marginal zone lymphomas (2020) (1)
- Prognostic Significance of the Postchemotherapy Positron Emission Tomography (PET)/Computed Tomography in Early-Stage Hodgkin Lymphoma: Can PET-Positive Patients Be Cured With Radiation Alone? (2016) (1)
- Lymphoma and Pregnancy-Reply. (2017) (1)
- Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma (2019) (1)
- Excellent Outcomes after Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma (2018) (1)
- Effectiveness of Very Low- and Low-Dose Radiation for Primary Cutaneous Anaplastic Large Cell Lymphoma (2016) (1)
- Management and Long-Term Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy (2020) (1)
- Oral Scientific SessionsPotential to Reduce Toxicity: Clinical and Dosimetric Predictors of Hypothyroidism After Radiation Therapy With IMRT for Hodgkin Lymphoma (2017) (1)
- Small Lymphocytic Lymphoma Presenting with Hypopituitarism. (2016) (1)
- Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816 (2020) (1)
- Poster ViewingBaseline PET-CT Does Not Predict Outcome in Localized, Low Tumor Burden Follicular Lymphoma (2017) (1)
- Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem Cell Transplant (ASCT) in Hodgkin's Lymphoma Patients at High Risk of Post-Transplant Recurrence—Comparison with a Concurrent Matched Cohort (2017) (1)
- Using Holistic Residency Applicant Review and Selection in Radiation Oncology to Enhance Diversity and Inclusion, an ASTRO SCAROP-ADROP-ARRO Collaboration. (2023) (0)
- Radiation As an Effective Salvage Therapy for Secondary CNS Lymphoma (2017) (0)
- Primary CNS Lymphoma (2017) (0)
- Postchemotherapy Positron Emission Tomography/Computed Tomography Scans in Early-Stage Hodgkin Lymphoma: Moving Beyond the Deauville 5-Point Scale (2016) (0)
- RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER (2019) (0)
- Restratifying Early-Stage Hodgkin Lymphoma Patients Using Novel Functional Imaging Parameters (2016) (0)
- Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma (2021) (0)
- Analyzing Patient Characteristics Who Received (DA) EPOCH-R for High Risk Diffuse Large B-Cell Lymphoma: MD Anderson Cancer Center Experience (2016) (0)
- The Role of Radiation Therapy in the Treatment of Primary Mediastinal B Cell Lymphoma Treated with Rituximab containing Regimens (2014) (0)
- Bone Involvement: A Poor Prognostic Factor in Stage IV Hodgkin Lymphoma (2015) (0)
- Prognostic Value of Disease Location in Secondary Central Nervous System Diffuse Large B-Cell Lymphoma (2020) (0)
- Factors Associated with the Improvement of Outcomes of High-Risk Relapsed Hodgkin Lymphoma (HL) Patients Receiving High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT): The MD Anderson Cancer Center Experience (2020) (0)
- Follicular Lymphoma of the Skin: Different Therapies Similar Outcome (2014) (0)
- Limited Utility of PET-CT and CT Imaging Beyond Treatment Completion in Limited Stage Hodgkin Lymphoma Patients (2019) (0)
- Notch1 activation confers transforming properties to primary human melanocytes and promotes human melanoma progression (2006) (0)
- SU-E-T-522: A Multi-Isocenter VMAT Technique for Cranio-Spinal Irradiation. (2014) (0)
- Does Skeletal Presentation Make a Difference in Outcomes of Diffuse Large B-cell Lymphoma? A Review of the 25-Year Experience With Treating Primary Bone Lymphoma (2014) (0)
- Multidisciplinary Management with Whole Abdominal IMRT of Desmoplastic Small Round Cell Tumor (2010) (0)
- Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement (2018) (0)
- Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy (2021) (0)
- List of Contributors (2019) (0)
- Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients with Relapsed and Refractory Large B-Cell Lymphoma (2022) (0)
- A call for an unbalanced force to combat racism and health disparity (2021) (0)
- How Much Did We Impact the Risk of Second Malignancies in Patients with Classical Hodgkin Lymphoma by Changing the Treatment Paradigm? (2020) (0)
- CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL (2021) (0)
- A Clinical Model of Progression to Multiple Myeloma in Solitary Plasmacytoma (2017) (0)
- Dosimetric Comparison of Intensity-Modulated Radiation Therapy via Breath Hold Technique and Proton Therapy With or Without Breath Hold for Mediastinal Lymphoma (2017) (0)
- The Easix (Endothelial Activation and Stress Index) Score Predicts for CAR T Related Toxicity in Patients Receiving Axicabtagene Ciloleucel (axi-cel) for Non-Hodgkin Lymphoma (NHL) (2020) (0)
- The Outcome of Limited-Stage Plasmablastic Lymphoma Treated With and Without Radiation Therapy: A Single-Institutional Experience (2014) (0)
- Maintenance Rituximab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) in the First Line Setting or at Relapse (2019) (0)
- Hodgkin Lymphoma Treatment: Modern Radiation Therapy, Lower Dose, Smaller Field, But the Risk of Lhermitte Sign Is Still There (2014) (0)
- Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma (2021) (0)
- P-197: Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies (2021) (0)
- Early-Stage Extranodal NK/T-cell Lymphoma: A Role for Elective Nodal Irradiation? (2018) (0)
- PHASE II TRIAL OF HIGH-DOSE GEMCITABINE/BUSULFAN/MELPHALAN WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR PRIMARY REFRACTORY OR POOR-RISK RELAPSED HODGKIN’S LYMPHOMA (2021) (0)
- DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME? (2019) (0)
- Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma (2020) (0)
- Radiation Therapy Improves Outcomes in Patients With Primary Testicular Diffuse Large B-cell Lymphoma (2016) (0)
- The Role of Radiation Therapy in Hematopoietic Stem Cell Transplantation (2019) (0)
- Radiomic Phenotypes of High and Low Lesion SUV Components for the Prediction of Refractory Disease in Hodgkin's Lymphoma Patients Treated with ABVD Based Therapy (2021) (0)
- A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma (2019) (0)
- Successful Management of Diffuse Large B-Cell Lymphoma Involving the Mesentery with Volumetric Image Guided Intensity Modulated Radiation Therapy (2018) (0)
- Controlling Central Nervous System Leukemia: Does the Extent of the Radiation Therapy Field Influence Outcomes? (2013) (0)
- Brentuximab Vedotin with Chemotherapy in Frontline Treatment of Classic Hodgkin Lymphoma Nodular Sclerosis Syncytial Variant (2020) (0)
- Peri-Stem Cell Transplant Toxicity after Craniospinal Irradiation: The Influence of Timing (2018) (0)
- Assessing the Displacement of Left Anterior Descending Artery (LAD) during Cardiac Motion for Radiotherapy of Breast Cancer (2010) (0)
- Association of Epstein-Barr Virus with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma (2020) (0)
- Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy (2019) (0)
- Evaluation of an Informal Virtual Medical Student Elective in Radiation Oncology During the COVID Era (2021) (0)
- Graft-Versus-Host Disease Following Radiation Therapy in Patients With a History of Allogeneic Stem Cell Transplant (2015) (0)
- Prognostic Value of Delta Lymphocyte Index (DLIx) in Patients with Large B-Cell Lymphoma (LBCL) Treated with Chimeric Antigen Receptor (CAR) T-Cell Therapy (2020) (0)
- Concurrent Radiation Therapy With the Antibody-Drug Conjugates Brentuximab Vedotin and Polatuzumab Vedotin. (2021) (0)
- In Response to Comment On: Why Racial Justice Matters in Radiation Oncology (2020) (0)
- Cutaneous CD4 + small/medium T‐cell lymphoproliferative disorder (2020) (0)
- A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma (2020) (0)
- Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience (2022) (0)
- Importance of PET-CT Radiomics Features in Outcomes Prognostication for Mediastinal Hodgkin Lymphoma (2017) (0)
- Omission of Cardiophrenic Lymph Nodes in the Treatment of Patients with Hodgkin Lymphoma Using Modified Involved Site Radiation Therapy: Lower Toxicity with No Added Failure (2017) (0)
- Why Racial Justice Matters in Radiation Oncology (2020) (0)
- Analyzing Resident Perceptions of Current Radiation Oncology Evaluation Methods (2022) (0)
- Dosimetric advantages of a “butterfly” technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin’s lymphoma (2014) (0)
- Response Adapted Ultra Low Dose Radiation Therapy for the Definitive Management of Orbital Indolent B-Cell Lymphoma (2022) (0)
- Circulating CD4:CD8 Ratio is Prognosticator of Response to Total Skin Electron Beam Radiation in Mycoses Fungoides (2017) (0)
- Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Axicabtagene Ciloleucel (axi-cel), in Patients with Refractory Large B-Cell Lymphoma (LBCL) (2021) (0)
- Utilization of Positron Emission Tomography/Computed Tomography Parameters to Identify Patients at Risk for Progression After Treatment With Dose-Adjusted R-EPOCH for Primary Mediastinal B-Cell Lymphoma (PMBCL) (2016) (0)
- Chemoradiation to Improve Local Control, and Thereby Overall Survival for Limited Stage Nasal NKTCL. (2021) (0)
- Post‐ABVD biopsy results, and not post‐ABVD FDG‐PET results, predict outcome in early‐stage Hodgkin lymphoma: response to Adams and Kwee (2019) (0)
- Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report (2021) (0)
- Radiation Therapy for Salivary Gland MALT Lymphoma: Ultra Low Dose Treatment Spares Salivary Function and Achieves Excellent Outcomes (2018) (0)
- Outcome of Patients with Classical Hodgkin Lymphoma (cHL) Relapsing after an Autologous Stem-Cell Transplant (ASCT) (2023) (0)
- Poster Viewing AbstractAcute and Late Toxicity of Bilateral Orbital Irradiation in the Management of Primary Intraocular Lymphoma (2016) (0)
- SU-F-R-14: PET Based Radiomics to Predict Outcomes in Patients with Hodgkin Lymphoma. (2016) (0)
- Women’s Representation among Lead Investigators of Clinical Trials in Oncology (2019) (0)
- In Reply to Smith et al. (2022) (0)
- COVID-Era Medical Student Education: Creation and Implementation of an Informal Virtual Elective in Radiation Oncology (2021) (0)
- Definitive Radiation Therapy for Stage I and II Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma: Report of a Prospective Study (2014) (0)
- Immune Therapies for Lymphomas: A Disruptive Technology With Opportunities for Radiation. (2018) (0)
- Primary Breast Diffuse Large B-Cell Lymphoma: Treatment Strategies and Patterns of Failure (2017) (0)
- Poster ViewingConsolidative Radiation Dose De-escalation in Primary CNS Lymphoma for Patients with an Incomplete Response to Methotrexate Based Chemotherapy (2017) (0)
- Clinical characteristics, outcomes and predictors of progression to multiple myeloma (MM) in 61 patients with solitary plasmacytoma (2015) (0)
- Impact of Patient Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation Patterns for Non-Hodgkin Lymphoma at a Major Academic Institution (2022) (0)
- Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma. (2021) (0)
- Rainbow IMRT and Volumetric Imaging for Anterior Mesenteric Targets. (2019) (0)
- Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease (2015) (0)
- EOMES+ Tr1-like Cells Are Enriched in Areas of NLPHL Group II (Patterns D to F) Supporting the Role of Tregs in Disease Recurrence/Progression (2022) (0)
- The Management of Primary Mediastinal B Cell Lymphoma Refractory to Dose-Adjusted R-EPOCH alone (2019) (0)
- Adjuvant Therapy Improves Outcomes in Completely Resected, Limited-Stage Follicular Lymphoma (2017) (0)
- The American Society for Radiation Oncology Workforce Taskforce Review of the United States Radiation Oncology Workforce Analysis. (2023) (0)
- Retrospective Review of Prognostic and Predictors Markers in Newly Diagnosed Angioimmunoblastic T Cell Lymphoma at UT MD Anderson Cancer Center (2020) (0)
- Brentuximab vedotin with chemotherapy for advanced stage untreated classic Hodgkin’s lymphoma in a real-world setting. (2020) (0)
- Pretreatment Neutrophil/Lymphocyte Ratio Predicts Relapse in Stage I and II Hodgkin Lymphoma (2016) (0)
- (P110) hodgkin lymphoma and pregnancy: treatment patterns and survival outcomes of women treated with modern chemotherapy and radiotherapy. (2015) (0)
- Intensity Modulated Radiation Therapy Using Frontal Technique With Active Breathing Control in the Treatment of Gastric MALT Lymphoma: Implications for Normal Tissue Sparing (2013) (0)
- Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma. (2022) (0)
- Outcomes of Patients with Extranodal Natural Killer/T-Cell Lymphoma: Single Institution Series (2021) (0)
- Proton Versus Photon Craniospinal Irradiation for Hematologic Malignancies Involving the CNS: Effectiveness and Toxicity in the Setting of Stem Cell Transplant (2016) (0)
- Radiation Therapy Is a Very Effective Modality in the Treatment of Mantle Cell Lymphoma, >80% Complete Disappearance of Disease Site in Heavily Pretreated Patients (2013) (0)
- Involved Site vs Extended Field Radiation Therapy for Multiple Myeloma of Long Bones after Internal Fixation (2018) (0)
- Avoiding Topical Agents Before Daily Radiotherapy: Debunking Dogma. (2018) (0)
- Outcomes of diffuse large b-cell lymphoma with MYC and/or BCL2 protein expression treated with intensive chemotherapy. (2016) (0)
- Prognostic Value of Body Composition in a Cohort of Elderly Pts with Newly Diagnosed Classical Hodgkin's Lymphoma: A Retrospective Single Center Study (2022) (0)
- Association of Smoking with Advanced Stage and Survival Outcomes in Classic Hodgkin's Lymphoma (2020) (0)
- Radiation Pneumonitis Risk after Bleomycin Toxicity in Hodgkin Lymphoma Patients (2015) (0)
- Endoscopic Mucosal Resection (EMR) for the Management of Solitary Extramedullary Plasmacytoma of the Esophagus: 846 (2014) (0)
- Validation of RPA and DS-GPA in Patients Treated with Upfront Radiosurgery Alone (2011) (0)
- "Protecting our Patients and Trainees: The Complex Consequences of the Dobbs Ruling." (2022) (0)
- Incidence and predictors of Lhermitte’s sign among patients receiving mediastinal radiation for lymphoma (2015) (0)
- Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial (2012) (0)
- Assessing the Role of Radiation Therapy for Primary Mediastinal Large B-Cell Lymphoma in the Setting of PET Avid Disease after Chemotherapy (2020) (0)
- Mitigating Bias in Recruitment: Attracting a Diverse, Dynamic Workforce to Sustain the Future of Radiation Oncology (2022) (0)
- Characteristics of Myeloma (MM) Patients (pts) with Central Nervous System (CNS) Involvement (2015) (0)
- M.D. Anderson experience of immune checkpoint inhibitor therapy in classical Hodgkin lymphoma. (2020) (0)
- SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation (2015) (0)
- Radiation Therapy can be Safely Incorporated Into Pre-Transplant Treatment Regimens for Patients With Multiple Myeloma. (2021) (0)
- The Impact of PET-CT on Rates of Progression from Solitary Plasmacytoma to Multiple Myeloma after Definitive Radiation Therapy (2019) (0)
- Implementation and Assessment of an Informal Virtual Elective for Medical Student Radiation Oncology Exploration During the COVID19 Pandemic: a Brief Report (2022) (0)
- Identification of Clinical Factors to Help Predict for Early Rapid MRI Progression (ERMP) of Brain Metastasis Patients Undergoing Gamma Knife Radiosurgery (2011) (0)
- A Multi-institutional Analysis of Consolidative Radiation Therapy Following Autologous Transplantation for Relapsed/Refractory Hodgkin Lymphoma. (2016) (0)
- Excellent Outcomes in Primary Cutaneous B-cell Lymphoma After Very Low Dose Radiation (2015) (0)
- Radiosurgery in Patients with “Radioresistant” Brain Metastases: Outcomes and Prognosis (2011) (0)
- CN-02MYELOPATHY FOLLOWING INTRATHECAL CHEMOTHERAPY: A CASE SERIES IN ADULTS. (2014) (0)
- Outcome of Patients with Central Nervous System Multiple Myeloma (CNS-MM) Treated with CNS-Directed Radiation Therapy (2022) (0)
- Involved Site and Reduced Dose Radiation Therapy for Multiple Myeloma: Should It be the New Standard? (2018) (0)
- Long-Term Outcomes after Autologous Stem Cell Transplant (ASCT) for Primary Central Nervous System Lymphoma (PCNSL) (2023) (0)
- Primary Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes (2017) (0)
- The American Society for Radiation Oncology Workforce Statement. (2022) (0)
- Long-term outcomes of allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma. (2021) (0)
- Clinical Outcomes of Patients with Breast Implant- Associated Anaplastic Large- Cell Lymphoma (BIA-ALCL) Treated with Chemotherapy and Brentuximab Vedotin (2022) (0)
- Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa (2015) (0)
- Dosimetric Lung Constraints and Neutrophil-Lymphocyte Ratio as Predictors of Radiation Pneumonitis in Lymphoma Patients treated with Mediastinal IMRT (2019) (0)
- CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL (2022) (0)
- Local Uncertainty Variation in DIBH-IMRT Treatments for Mediastinal Lymphoma and the Implications on Setup Margin Selection (2017) (0)
- Salvage Radiation Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma (2015) (0)
- Randomized Phase III Clinical Trial to Compare Topical Hyaluronic Acid-based and Petrolatum-based Gels for Radiation Dermatitis in Breast Cancer Patients (2010) (0)
- Grade 3 Follicular Lymphoma Patients Can Experience Favorable Outcomes With Various Management Strategies (2017) (0)
This paper list is powered by the following services:
Other Resources About Chelsea Pinnix
What Schools Are Affiliated With Chelsea Pinnix?
Chelsea Pinnix is affiliated with the following schools:
